In order to confirm the expression of GARP on GB tumor cells, a commercially available GB cell line (T98G), three patient-derived GB cell lines (#1043, #1051, #1063), and a melanoma cell line (MaMel-19) were analyzed by flow cytometry and confocal microscopy (Figure 3 and Figure 4). The gene discussed is LRRC32; the disease is neoplasm.